Susquehanna International Group, LLP Aquestive Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 155,032 shares of AQST stock, worth $688,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares

155,032

Previous 76,819 101.81%

Holding current value

$688,342

Previous $199,000 287.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.4 - $5.09 $187,711 - $398,104	78,213 Added 101.81%	155,032 $772,000
Q2 2024 Aug 15, 2024	SELL	$2.31 - $4.5 $1.21 Million - $2.36 Million	-525,170 Reduced 87.24%	76,819 $199,000
Q1 2024 May 07, 2024	BUY	$2.01 - $6.09 $1.13 Million - $3.43 Million	563,732 Added 1473.54%	601,989 $2.56 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $2.47 $33,591 - $64,318	26,040 Added 213.15%	38,257 $77,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.24 $121,473 - $181,399	-80,982 Reduced 86.89%	12,217 $18,000
Q2 2023 Aug 11, 2023	SELL	$1.06 - $2.49 $24,457 - $57,451	-23,073 Reduced 19.84%	93,199 $153,000
Q1 2023 May 16, 2023	BUY	$0.72 - $1.15 $83,715 - $133,712	116,272 New	116,272 $132,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $1.73 $15,025 - $41,260	23,850 New	23,850 $28,000
Q2 2022 Aug 15, 2022	SELL	$0.64 - $2.57 $31,047 - $124,673	-48,511 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.28 - $4.26 $271,155 - $506,633	-118,928 Reduced 71.03%	48,511 $126,000
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $391,748 - $676,271	106,165 Added 173.26%	167,439 $651,000
Q3 2021 Nov 15, 2021	SELL	$3.25 - $4.66 $126,867 - $181,907	-39,036 Reduced 38.92%	61,274 $267,000
Q2 2021 Aug 11, 2021	SELL	$3.29 - $5.21 $97,262 - $154,023	-29,563 Reduced 22.76%	100,310 $398,000
Q1 2021 May 17, 2021	BUY	$4.17 - $6.73 $278,134 - $448,884	66,699 Added 105.58%	129,873 $675,000
Q4 2020 Feb 16, 2021	SELL	$4.65 - $7.79 $294,986 - $494,182	-63,438 Reduced 50.1%	63,174 $338,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $9.09 $115,368 - $254,538	28,002 Added 28.4%	126,612 $615,000
Q1 2020 May 15, 2020	BUY	$1.54 - $6.75 $98,883 - $433,417	64,210 Added 186.66%	98,610 $216,000
Q4 2019 Feb 14, 2020	BUY	$3.06 - $8.78 $105,264 - $302,032	34,400 New	34,400 $200,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

46.8M

Call Options Held

517K

Put Options Held

207K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $237M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Aquestive Therapeutics, Inc. Transaction History